Mike Orchard

This inventor holds 15 USPTO granted patents, plus 5 CIPO patents and 10 EPO patents. Top assignees: Genkyotex Sa, Genkyotex Suisse Sa, Calliditas Therapeutics Suisse Sa. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mike Orchard. Retrieved from https://idiyas.com/inventor/mike-orchard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 40.0

CIPO Patents = 5

EPO Patents = 10 (Patent Applications = 17)

Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 97(Granted Patents)

Location History:

Oxfordshire, GB (2018)
Oxon, GB (2012 - 2020)

Company Filing History:

Calliditas Therapeutics Suisse Sa

patents

Years Active: 2012-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE50878 - Pyrazolo pyridine derivatives as NADPH oxidase inhibitors (2026-05-05),

2. 10772891 - Pyrazolo pyridine derivatives as NADPH oxidase inhibitors (2020-09-15),

3. 9974791 - Pyrazolo pyridine derivatives as NADPH oxidase inhibitors (2018-05-22),

4. 9096588 - Pyrazolo pyridine derivatives as NADPH oxidase inhibitors (2015-08-04),

5. 9073919 - Pyrazolo pyridine derivatives as NADPH oxidase inhibitors (2015-07-07),

6. 9012449 - Pyrazolo pyridine derivatives as NADPH oxidase inhibitors (2015-04-21),

7. 9006238 - Pyrazolo pyridine derivatives as NADPH oxidase inhibitors (2015-04-14),

8. 8940760 - Pyrazolo pyridine derivatives as NADPH oxidase inhibitors (2015-01-27),

9. 8865758 - Pyrazolo piperidine derivatives as NADPH oxidase inhibitors (2014-10-21),

10. 8748456 - Pyrazolo piperidine derivatives as NADPH oxidase inhibitors (2014-06-10),

11. 8481562 - Pyrazolo pyridine derivatives as NADPH oxidase inhibitors (2013-07-09),

12. 8455486 - Pyrazolo pyridine derivatives as NADPH oxidase inhibitors (2013-06-04),

13. 8455485 - Pyrazolo pyridine derivatives as NADPH oxidase inhibitors (2013-06-04),

14. 8389518 - Pyrazolo pyridine derivatives as NADPH oxidase inhibitors (2013-03-05),

15. 8288432 - Tetrahydroindole derivatives as NADPH oxidase inhibitors (2012-10-16),

Title: Mike Orchard: Innovator in Pharmaceutical Chemistry

Introduction

Mike Orchard is a distinguished inventor based in Oxon, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds aimed at treating various medical conditions. With a total of 15 patents to his name, Orchard's work has garnered attention in the scientific community.

Latest Patents

Among his latest inventions are pyrazolo pyridine derivatives, which serve as NADPH oxidase inhibitors. These compounds are detailed in his patent, which describes their pharmaceutical compositions and their potential use in treating disorders related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase). This innovative approach highlights Orchard's commitment to advancing medical science through his research.

Career Highlights

Throughout his career, Mike Orchard has worked with notable companies, including Genkyotex SA and Genkyotex Suisse SA. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Orchard has collaborated with several professionals in his field, including Patrick Naxos Page and Francesca Gaggini. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Mike Orchard's contributions to pharmaceutical chemistry through his innovative patents and collaborations underscore his role as a leading inventor in the industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.